UBS Group Cuts Envista (NYSE:NVST) Price Target to $21.00

Envista (NYSE:NVST) had its price target reduced by UBS Group from $23.00 to $21.00 in a report released on Monday,Benzinga reports. UBS Group currently has a neutral rating on the stock.

Other equities research analysts have also issued research reports about the stock. New Street Research set a $19.00 price target on shares of Envista in a report on Thursday, March 6th. Piper Sandler boosted their price objective on shares of Envista from $17.00 to $18.00 and gave the stock a “neutral” rating in a research note on Monday, February 3rd. Wells Fargo & Company boosted their price objective on shares of Envista from $20.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 6th. Morgan Stanley reduced their price objective on shares of Envista from $20.00 to $19.00 and set an “equal weight” rating for the company in a research note on Thursday, March 6th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Envista in a research note on Thursday, March 6th. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $20.18.

Envista Trading Down 2.4 %

Shares of NVST opened at $16.73 on Monday. Envista has a 1-year low of $15.15 and a 1-year high of $23.00. The company has a 50-day moving average of $20.10 and a 200 day moving average of $19.67. The firm has a market capitalization of $2.88 billion, a price-to-earnings ratio of -2.58, a PEG ratio of 1.27 and a beta of 1.33. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.04 and a quick ratio of 1.76.

Envista (NYSE:NVST) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.24 EPS for the quarter, beating the consensus estimate of $0.23 by $0.01. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. On average, research analysts expect that Envista will post 1 EPS for the current year.

Institutional Trading of Envista

Several large investors have recently made changes to their positions in NVST. Franklin Resources Inc. boosted its holdings in shares of Envista by 72.6% in the 4th quarter. Franklin Resources Inc. now owns 6,854,506 shares of the company’s stock valued at $132,223,000 after acquiring an additional 2,882,844 shares during the last quarter. Iron Triangle Partners LP purchased a new stake in shares of Envista in the 3rd quarter valued at $43,262,000. Brickwood Asset Management LLP purchased a new stake in shares of Envista in the 4th quarter valued at $40,037,000. Norges Bank purchased a new stake in shares of Envista in the 4th quarter valued at $38,052,000. Finally, Point72 Asset Management L.P. purchased a new stake in shares of Envista in the 3rd quarter valued at $37,559,000.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.